Molecular Biomarkers of Disease for Diagnosis and Drug Development (90 visite)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2019; 2626(24): 1922-1923.
Tipo di articolo: Journal Article, Editorial, Introductory Journal Article
Impact factor: 3.9, Impact factor a 5 anni: 3.7
Url: Non disponibile.
Parole chiave: Bacteria Chemistry, Bacterial Infections Diagnosis Physiopathology, Biomarkers Analysis, Tumor Analysis Physiology, Drug Development, Humans, Neoplasms Diagnosis Physiopathology
Affiliazioni:
*** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini CNR. Via Mezzocannone 16. I-80134 Naples, Italy.,
Riferimenti:
Non disponibile.
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2019; 2626(24): 1922-1923.
Tipo di articolo: Journal Article, Editorial, Introductory Journal Article
Impact factor: 3.9, Impact factor a 5 anni: 3.7
Url: Non disponibile.
Parole chiave: Bacteria Chemistry, Bacterial Infections Diagnosis Physiopathology, Biomarkers Analysis, Tumor Analysis Physiology, Drug Development, Humans, Neoplasms Diagnosis Physiopathology
Affiliazioni:
*** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini CNR. Via Mezzocannone 16. I-80134 Naples, Italy.,
Riferimenti:
Non disponibile.
Non disponibile.
Nessun risultato. |
Nessun risultato. |
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Berisio R
* Molecular Biomarkers of Disease for Diagnosis and Drug Development (2 visite)
Curr Med Chem (ISSN: 0929-8673linking), 2019; 26(24): 4498-4500.
Impact Factor: 3.469
Dettagli Esporta in BibTeX Esporta in EndNote
Squeglia F, RomanoM, Ruggiero A, Berisio R
* Molecular players in Tuberculosis drug development: another break in the cell wall (150 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2017 Feb 08; 24: 3954-3969.
Impact Factor: 3.469
Dettagli Esporta in BibTeX Esporta in EndNote
Angapelly S, Ramya PVS, Angeli A, Monti SM, Buonanno M, Alvala M, Supuran CT, Arifuddin M
* Discovery of 4-sulfamoyl-phenyl-β-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors (88 visite)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391), 2017; 25(2): 539-544.
Impact Factor: 2.881
Dettagli Esporta in BibTeX Esporta in EndNote
Milardi D, Pappalardo M
* Molecular dynamics: New advances in drug discovery (222 visite)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 0223-5234linking), 2015; 91: 1-3.
Impact Factor: 3.902
Dettagli Esporta in BibTeX Esporta in EndNote
Morelli G, Saviano M, Grieco P
* The renaissance era of peptides in drug discovery at the 14th Naples workshop on bioactive peptides (217 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617linking), 2015; 21(5): 321-322.
Impact Factor: 1.951
Dettagli Esporta in BibTeX Esporta in EndNote
Di Stasi R, Diana D, Capasso D, Palumbo R, Romanelli A, Pedone C, Fattorusso R, D'Andrea LD
* VEGFR1(D2) in drug discovery: Expression and molecular characterization (181 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2010; 94(6): 800-809.
Impact Factor: 2.572
Dettagli Esporta in BibTeX Esporta in EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (204 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
Dettagli Esporta in BibTeX Esporta in EndNote
7 Records (7 escludendo Abstract e Conferenze).
Impact factor totale: 23.067 (23.067 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 24.934 (24.934 escludendo Abstract e Conferenze).
Impact factor totale: 23.067 (23.067 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 24.934 (24.934 escludendo Abstract e Conferenze).
Esporta in BibTeX Esporta in EndNote
Ultima modifica di Marco Comerci in data Thursday 13 February 2020, 8:59:15
90 visite. Ultima visita in data Thursday 13 February 2020, 8:59:16
ibb.cnr.it